Cardiovascular Disease Incidence and Risk Mitigation in Patients with Locally Advanced or Metastatic Prostate Cancer on ADT

September 30th 2022

Expert perspectives on the risk of cardiovascular disease as it exists in the context of androgen deprivation therapy (ADT) and prostate cancer.

September 30th 2022

Shared insight on a timeline of clinical studies contextualizing cardiovascular disease in the setting of prostate cancer management.

September 30th 2022

Comprehensive insight regarding strategies to mitigate cardiovascular risk in patients on therapy for prostate cancer.

December 8th 2022

Centering focus on a patient case of cardiovascular risk and prostate cancer, experts share their perspective on management strategies.